E. coli L-asparaginaseでアナフィラキシーを発現したが, Erwinia製剤で安全に寛解導入し得たALLの1例

症例は6歳の男児.急性リンパ性白血病の診断で治療を行っていたが, 31カ月後に骨髄再発を認めた.この間Eschericnia coli L-Aspを2,000単位/m2/回×42回点滴静注で使用していた.再寛解導入療法を開始後, 8回目のL-Asp静注時にアナフィラキシーが認められ, 以後L-Aspを除く他の治療を試みたが寛解導入不能であった.MTT色素還元法による薬剤感受性試験の結果, L-Aspが有効であったため, Erwinia L-Asp, Ara-C, methotrexate, vincristine, prednisoloneの併用療法を行ったところ過敏反応を認めず完全寛解が得ら...

Full description

Saved in:
Bibliographic Details
Published in日本小児血液学会雑誌 Vol. 8; no. 2; pp. 163 - 167
Main Authors 具志堅, 俊樹, 楚南, 盛章, 百名, 伸之
Format Journal Article
LanguageJapanese
Published 特定非営利活動法人 日本小児血液・がん学会 1994
Online AccessGet full text
ISSN0913-8706
1884-4723
DOI10.11412/jjph1987.8.163

Cover

Abstract 症例は6歳の男児.急性リンパ性白血病の診断で治療を行っていたが, 31カ月後に骨髄再発を認めた.この間Eschericnia coli L-Aspを2,000単位/m2/回×42回点滴静注で使用していた.再寛解導入療法を開始後, 8回目のL-Asp静注時にアナフィラキシーが認められ, 以後L-Aspを除く他の治療を試みたが寛解導入不能であった.MTT色素還元法による薬剤感受性試験の結果, L-Aspが有効であったため, Erwinia L-Asp, Ara-C, methotrexate, vincristine, prednisoloneの併用療法を行ったところ過敏反応を認めず完全寛解が得られた.この後測定した患児の抗L-Asp IgG抗体価は94U/mlと高値であった.以上より過敏反応でE. coli製剤を継続使用できない症例にも, Erwinia製剤は安全に使用でき, 有用であると思われた.
AbstractList 症例は6歳の男児.急性リンパ性白血病の診断で治療を行っていたが, 31カ月後に骨髄再発を認めた.この間Eschericnia coli L-Aspを2,000単位/m2/回×42回点滴静注で使用していた.再寛解導入療法を開始後, 8回目のL-Asp静注時にアナフィラキシーが認められ, 以後L-Aspを除く他の治療を試みたが寛解導入不能であった.MTT色素還元法による薬剤感受性試験の結果, L-Aspが有効であったため, Erwinia L-Asp, Ara-C, methotrexate, vincristine, prednisoloneの併用療法を行ったところ過敏反応を認めず完全寛解が得られた.この後測定した患児の抗L-Asp IgG抗体価は94U/mlと高値であった.以上より過敏反応でE. coli製剤を継続使用できない症例にも, Erwinia製剤は安全に使用でき, 有用であると思われた.
Author 百名, 伸之
具志堅, 俊樹
楚南, 盛章
Author_xml – sequence: 1
  fullname: 具志堅, 俊樹
  organization: 琉球大学医学部小児科
– sequence: 1
  fullname: 楚南, 盛章
  organization: 琉球大学医学部小児科
– sequence: 1
  fullname: 百名, 伸之
  organization: 琉球大学医学部小児科
BookMark eNo9kD9Lw0AAxQ-pYK2dXfsBTL3LXXJ3Yy31DwRcdA7X5Nom1LYkBXFwSEqHqigIIuIgWKWKWN0E0X6ZM7Qfw_p3eLzhvd8b3jxINZoNCcAignmECNKXfb9VQ5zRPMsjE8-ANGKMaITqOAXSkCOsMQrNOZANQ68MocEYhISmwX4pn3OadS9naSJsiUBUvYYIpYoGKr5WnQPVOVNxX3XuVfyo4hfVeVPx6fjidXwyUtG5iq5UdLSUKwW7XsMTk_570ruZssmwl3TvVPSQPF1OBv3k-Tjp3k77yegLKViWioboY3S4AGYroh7K7K9nwPZqaau4rlmbaxvFgqX5iGOoUewa0jAYcgkXjGBZNjlzKhRKTjClwhAO5CY2uMFdySnhWGIOSZkSveIKAnEGrPzs-mFbVKXdCrwdEezZImh7Tl3af-_ZzNa_Nf3wP3RqIrB9gT8BACOL4Q
ContentType Journal Article
Copyright (社)日本複写権センター
Copyright_xml – notice: (社)日本複写権センター
DOI 10.11412/jjph1987.8.163
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
EISSN 1884-4723
EndPage 167
ExternalDocumentID article_jjph1987_8_2_8_2_163_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
KQ8
RJT
ID FETCH-LOGICAL-j1930-73d5e5581d49a843eb698cf70e94377a5ac09635959de97493e3904b742fda403
ISSN 0913-8706
IngestDate Wed Sep 03 06:29:02 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 2
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j1930-73d5e5581d49a843eb698cf70e94377a5ac09635959de97493e3904b742fda403
OpenAccessLink https://www.jstage.jst.go.jp/article/jjph1987/8/2/8_2_163/_article/-char/ja
PageCount 5
ParticipantIDs jstage_primary_article_jjph1987_8_2_8_2_163_article_char_ja
PublicationCentury 1900
PublicationDate 19940000
PublicationDateYYYYMMDD 1994-01-01
PublicationDate_xml – year: 1994
  text: 19940000
PublicationDecade 1990
PublicationTitle 日本小児血液学会雑誌
PublicationTitleAlternate 日小血会誌
PublicationYear 1994
Publisher 特定非営利活動法人 日本小児血液・がん学会
Publisher_xml – name: 特定非営利活動法人 日本小児血液・がん学会
References 5) Jaffe N, Traggis D, Das L, et al : L-Asparaginase in the treatment of neoplastic disease in children. Cancer 31 : 942-949, 1971
12) 月本一郎, 松井純一, 岩下弘子, 他 : 抗L-asparaginaseIgG抗体測定法の改良とその臨床的考察.臨床血液33 : 24-29, 1992
1) Ohnuma T, Holland JF, Meyer P : Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli. Cancer 30 : 376-378, 1972
10) King OY, Wilbur JR, Mumfor DM, et al : Therapy with Erwinia L-asparaginase in children with acute leukemia after anaphylaxis to E. coli L-asparaginase. Cancer 33 : 611-614, 1974
3) Broome JD : Evidence that the L-asparaginase of guinea pig serum is responsible for its anti-lymphoma effects. Nature 191 : 1114-1115, 1961
9) Oettgen HF, Stephenson PA, Schwarts MK, et al : Toxicity of E. coli L-asparaginase in man. Cancer 25 : 253, 1970
2) Steinherz P, Meyers P, Wollner N, et al : Reinduction therapy for advanced or refractory acute lymphoblastic leukemia of childhood. Cancer 63 : 1472-1476, 1989
13) Billett AL,.Carls A, Gelber RD, et al : Allergic reac-tions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase. Cancer 70 : 201-206, 1992
7) Land VJ, Sutow WW, Fernbach DJ, et al : Toxicity of L-asparaginase in children with advanced leukemia. Cancer 30 : 339-347, 1972
6) Clavell LA, Gelber RD, Cohen HJ, et al : Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. N Engl J Med 315 : 657-663, 1986
11) Hongo T, Fujii Y, Igarashi Y : An in vitro chemosen-sitivity test for the screening of anti-cancer drugs in childhood leukemia. Cancer 65 : 1263-1272, 1990
4) Whitecar JP Jr, Bodey GP, Harris JE, et al : Current concepts : L-Asparaginase. N Engl J Med 282 : 732-734, 1970
8) Ertel IJ, Nesbit ME, Hammond D, et al : Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia : a report from the Children's Cancer Study Group. Cancer Res 39 : 3893-3896, 1979
References_xml – reference: 2) Steinherz P, Meyers P, Wollner N, et al : Reinduction therapy for advanced or refractory acute lymphoblastic leukemia of childhood. Cancer 63 : 1472-1476, 1989
– reference: 5) Jaffe N, Traggis D, Das L, et al : L-Asparaginase in the treatment of neoplastic disease in children. Cancer 31 : 942-949, 1971
– reference: 3) Broome JD : Evidence that the L-asparaginase of guinea pig serum is responsible for its anti-lymphoma effects. Nature 191 : 1114-1115, 1961
– reference: 8) Ertel IJ, Nesbit ME, Hammond D, et al : Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia : a report from the Children's Cancer Study Group. Cancer Res 39 : 3893-3896, 1979
– reference: 9) Oettgen HF, Stephenson PA, Schwarts MK, et al : Toxicity of E. coli L-asparaginase in man. Cancer 25 : 253, 1970
– reference: 7) Land VJ, Sutow WW, Fernbach DJ, et al : Toxicity of L-asparaginase in children with advanced leukemia. Cancer 30 : 339-347, 1972
– reference: 12) 月本一郎, 松井純一, 岩下弘子, 他 : 抗L-asparaginaseIgG抗体測定法の改良とその臨床的考察.臨床血液33 : 24-29, 1992
– reference: 10) King OY, Wilbur JR, Mumfor DM, et al : Therapy with Erwinia L-asparaginase in children with acute leukemia after anaphylaxis to E. coli L-asparaginase. Cancer 33 : 611-614, 1974
– reference: 13) Billett AL,.Carls A, Gelber RD, et al : Allergic reac-tions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase. Cancer 70 : 201-206, 1992
– reference: 6) Clavell LA, Gelber RD, Cohen HJ, et al : Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. N Engl J Med 315 : 657-663, 1986
– reference: 11) Hongo T, Fujii Y, Igarashi Y : An in vitro chemosen-sitivity test for the screening of anti-cancer drugs in childhood leukemia. Cancer 65 : 1263-1272, 1990
– reference: 4) Whitecar JP Jr, Bodey GP, Harris JE, et al : Current concepts : L-Asparaginase. N Engl J Med 282 : 732-734, 1970
– reference: 1) Ohnuma T, Holland JF, Meyer P : Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli. Cancer 30 : 376-378, 1972
SSID ssib005880047
ssj0003236711
ssib053390765
ssib002003923
ssib058493933
Score 1.392524
Snippet 症例は6歳の男児.急性リンパ性白血病の診断で治療を行っていたが, 31カ月後に骨髄再発を認めた.この間Eschericnia coli L-Aspを2,000単位/m2/回×42回点滴静注で使用していた.再寛解導入療法を開始後, 8回目のL-Asp静注時にアナフィラキシーが認められ,...
SourceID jstage
SourceType Publisher
StartPage 163
Title E. coli L-asparaginaseでアナフィラキシーを発現したが, Erwinia製剤で安全に寛解導入し得たALLの1例
URI https://www.jstage.jst.go.jp/article/jjph1987/8/2/8_2_163/_article/-char/ja
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 日本小児血液学会雑誌, 1994/04/30, Vol.8(2), pp.163-167
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1Na9RANJR68SKKit_swTnVrPmazAyeMmmWolUQWuhtSTYJdg-12BZB8LC79FAVBUFEPQhWqSJWb4Jo_0xc2p_he5NJN8UebIXs8jLz3ps3772deS87MzGMy0KwPGWxbfpCJKaX-5nJ_dw1RU5hOoEYOnNwg_PNW_7UrHd9js6Njb-urVpaWU6anQf77is5jFWhDOyKu2QPYNldplAAMNgXvsHC8P1PNo6aE2DH-YlpM17CM7zxHQtLGYlciA9JwBTgkMBRAFyBBgStqlxdEoiqZFIDkukqGeoSAXwYEYLIAAHeIjLSbQlWAS0N8LAcZe_PL8zHJOLYlATelHBBAq8mIyVBhIVYBTCvqqSqahEhFTlTwlIiLcKjCpnW2qcoTk2QYHq6YhXZJPKwmst6ME4iHwmQCwAhCcKqgZZuQFiqbRvXgwCOhMtRYk2SwFc8QyJAGwKlFLZCDqDvlRtrNrIUr6XlDCwsBPUoDi1lFx97LsWI0Ee5kDdwmERChc9UQxIBUFBgjfBLyyjNgNRAUvEPieQKEFX3U73rcfR4V9lTIEppDt0naLdkqLqOknDlKXAL_JSBuFTeBCWlW3noHbJ0NEur7TA6Ll1PjrxJ-6D7t_rrT5tt18S_1Muwo5xrOfdMj5XbzavJmNfGHKc2sdp6Gsz0Hdt_-vdsPE-42128gw_Tmry5S7fnTHX9i21XiG3edtQH0NtVJW57bHch9zriMGbjcuEbt2upOe5qr4XWFCbC2j_YkEUJi41WEECcL1yhUyuMEl08OlG9HnxXN_rkMezE1b1dgPC4C8litdBUxb4zx41jOmltBKXIJ4yxbnzSeBg1Gzj6NPaOPkVvo-i_KwaPisGLor9eDD4V_S9F_3sx-Fn0n2-_-rH9bKvovSx6b4vekysNPULsrP8arr0H2uHm2nD1Y9H7PPz6Zmdjffjt6XD1A-APt5AEftNFb9P-vfX4lDHbimbCKVO_zMXsQo5omcxNaUZhAkg9EXPPzRJf8E7OrEx4LmMxjTsWBANUUJFmgoG2MtCglzDPydPYs9zTxvjC3YXsjNGgSUpzkYsk8VIIOShkHDbNOriHP7US1z9rXCu11V4sT-xpH8Te5_6L-rxxtDxtHR_SXjDGl--tZBchbVlOLin_-QPdQwMT
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=E.+coli+L-asparaginase%E3%81%A7%E3%82%A2%E3%83%8A%E3%83%95%E3%82%A3%E3%83%A9%E3%82%AD%E3%82%B7%E3%83%BC%E3%82%92%E7%99%BA%E7%8F%BE%E3%81%97%E3%81%9F%E3%81%8C%2C+Erwinia%E8%A3%BD%E5%89%A4%E3%81%A7%E5%AE%89%E5%85%A8%E3%81%AB%E5%AF%9B%E8%A7%A3%E5%B0%8E%E5%85%A5%E3%81%97%E5%BE%97%E3%81%9FALL%E3%81%AE1%E4%BE%8B&rft.jtitle=%E6%97%A5%E6%9C%AC%E5%B0%8F%E5%85%90%E8%A1%80%E6%B6%B2%E5%AD%A6%E4%BC%9A%E9%9B%91%E8%AA%8C&rft.au=%E5%85%B7%E5%BF%97%E5%A0%85%2C+%E4%BF%8A%E6%A8%B9&rft.au=%E6%A5%9A%E5%8D%97%2C+%E7%9B%9B%E7%AB%A0&rft.au=%E7%99%BE%E5%90%8D%2C+%E4%BC%B8%E4%B9%8B&rft.date=1994&rft.pub=%E7%89%B9%E5%AE%9A%E9%9D%9E%E5%96%B6%E5%88%A9%E6%B4%BB%E5%8B%95%E6%B3%95%E4%BA%BA%E3%80%80%E6%97%A5%E6%9C%AC%E5%B0%8F%E5%85%90%E8%A1%80%E6%B6%B2%E3%83%BB%E3%81%8C%E3%82%93%E5%AD%A6%E4%BC%9A&rft.issn=0913-8706&rft.eissn=1884-4723&rft.volume=8&rft.issue=2&rft.spage=163&rft.epage=167&rft_id=info:doi/10.11412%2Fjjph1987.8.163&rft.externalDocID=article_jjph1987_8_2_8_2_163_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0913-8706&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0913-8706&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0913-8706&client=summon